Literature DB >> 23419841

A relationship between hallucination proneness and character and temperament: a mediating role of meta-cognitive beliefs in a non-clinical sample.

Łukasz Gawęda1, Andrzej Kokoszka.   

Abstract

We investigated a mediating role of meta-cognitions in the relationship between Cloninger's temperament and character dimensions and hallucination proneness among healthy subjects (n=135). Two character dimensions-self-directedness and self-transcendence-were related to hallucination proneness. Negative beliefs about uncontrollability of thoughts partially mediated the relationship between these two character dimensions and hallucination proneness.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23419841     DOI： 10.1016/j.psychres.2013.01.027

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


  4 in total

1.  The relationship between temperament and character and subclinical psychotic-like experiences in healthy adults.

Authors:  G C Nitzburg; A K Malhotra; P DeRosse
Journal:  Eur Psychiatry       Date:  2014-01-16       Impact factor: 5.361

2.  Examining the Psychosis Continuum.

Authors:  Pamela DeRosse; Katherine H Karlsgodt
Journal:  Curr Behav Neurosci Rep       Date:  2015-05-01

3.  Measurement of Unwanted Thought Suppression Strategies with the Thought Control Questionnaire in the General Polish Population: A Confirmatory Factor Analysis and Validation.

Authors:  Remigiusz Szczepanowski; Ewelina Cichoń; Tomasz Niemiec; Beata E Andrzejewska; Monika Wójta-Kempa
Journal:  Psychol Res Behav Manag       Date:  2021-02-12

4.  Short-term intensive psychodynamic group therapy versus cognitive-behavioral group therapy in day treatment of anxiety disorders and comorbid depressive or personality disorders: study protocol for a randomized controlled trial.

Authors:  Hubert Suszek; Paweł Holas; Tomasz Wyrzykowski; Steinar Lorentzen; Andrzej Kokoszka
Journal:  Trials       Date:  2015-07-29       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.